In partnership with

Yes, that Arnold Schwarzenegger.

He has a newsletter on beehiiv. So do Codie Sanchez, Jay Shetty, David Begnaud, Colin & Samir, and Joanna Stern.

They could publish just about anywhere. They chose beehiiv to build a direct connection with the people who want to hear from them most. And you can do the same, whether you’re world-famous or just at the start of your plan for world domination.

THE WEEK OF OCTOBER 12, 2026

GET READY…

The fourth quarter is off to the races. We’re taking a moment to focus on quantum computing, data center buildout news and, of course, we’re ready for the Anthropic IPO filing any day now.

Check out our website! With it’s repository of former notes and a searchable research database at https://epistrophy.beehiiv.com.

LFG! 👇

"Money (L'Argent)"
by Félix Vallotton, 1897
(from Intimités, an edition of 30; the wood blocks were destroyed after printing)

The pitch is in the lit corner and the bill is in the dark.
Source: MoMA

Table of Contents

TWEET OF THE WEEK

EPISTROPHY IN THE NEWS 🗞️

I joined Nicole Petallides on Schwab Network to talk about where quantum computing stands headed into the last quarter of the year. With revenues of $80.1 million, IonQ (IONQ: NYSE) was more than the other four listed hardware companies combined, and that it came with a $337.2 million operating loss. We talked about IonQ’s claim that its Superion 256 fits a standard server rack, but I probably should’ve pointed out that the claim is unverified because the company has published little by way of power, cooling or fidelity figures.

I joined Roger Peterson on Bloomberg Markets to talk about what we know and what we still don’t know about Anthropic after Reuters got the first look at its IPO prospectus. There are so many questions that could’ve been answered. Safe to say news of 2026 revenue at $4.6 billion yielding a net loss of about $42 billion and $518 billion of compute obligations wasn’t enough for me.

AVAILABILITY NEXT WEEK

In San Francisco all week. I’m available for interviews, background or client calls — and preparing for IPO filing from Anthropic! 👆

Written reports are available to clients, our IPO reports (dubbed “The Quiet Period”) for $5,000. Video summaries on YouTube, and of course our popular summaries of the summaries on Instagram, TikTok and YouTube Shorts.

THE WEEK AHEAD 📆

TICKER

NAME

MARKET CAP

DATE

TYPE

WDAY

Workday Rising 2026

Oct 12

Conference

AMD

OCP Global Summit 2026 (Lisa Su opening keynote, Oct 12)

Oct 12

Conference

NVDA

OCP Global Summit 2026 (Ian Buck keynote, Oct 12)

Oct 12

Conference

LSCC

OCP Global Summit 2026 (Ford Tamer keynote, Oct 13)

Oct 12

Conference

SEMICON West 2026

Conference

WDAY

Workday Financial Analyst Day

Oct 13

Investor Day

AVGO

VMware Explore on Tour Frankfurt

Oct 13

Conference

CPI

Consumer Price Index

Oct 14

Economic Event

MDB

MongoDB.local Dallas

Oct 14

Conference

PPI

Producer Price Index

Oct 15

Economic Event

RS

Advance Retail & Food Services Sales

Oct 15

Economic Event

CRM

AIforce World Tour London

Oct 15

Conference

IP

Industrial Production & Capacity Utilization

Oct 16

Economic Event

NET

Cloudflare Connect 2026

$122 B

Oct 19

Conference

IT

Gartner IT Symposium/Xpo (Orlando)

Oct 19

Conference

IBM

IBM Common Stock

$208 B

Oct 20

Earnings

NHC

New Residential Construction

Oct 20

Economic Event

NVDA

NVIDIA GTC Berlin 2026

$5,723 B

Oct 20

Conference

NOW

ServiceNow World Forum London 2026

$143 B

Oct 20

Conference

VEEV

Veeva R&D and Quality Summit 2026

$46 B

Oct 20

Conference

ZM

Zoomtopia 2026

Oct 20

Conference

ESTC

Elastic{ON} Amsterdam 2026

Oct 20

Conference

AVGO

VMware Explore on Tour Tokyo

Oct 20

Conference

SAP

SAP SE

$260.433 B

Oct 21

Earnings

NOK

Nokia Oyj

$60 B

Oct 22

Earnings

We certify that (1) the views expressed in this report accurately reflect our views about all of the subject companies and securities and (2) no part of my compensation was, is or will be directly related to the specific recommendations or views expressed in this report.

Important disclosures

Important disclosures are available by calling (347) 619-2489 or writing to Epistrophy Capital Research, One Ferry Building, Suite 201, San Francisco, CA 94111.

Epistrophy Capital Research is an independent research provider and does not operate as a financial institution. Epistrophy explicitly does not provide investment advice, stock recommendations, or solicitations to buy or sell any securities.

The research reports provided by Epistrophy Capital Research contain opinions derived from publicly available information, issuer communications, recognized statistical services, and other reputable sources considered reliable. However, Epistrophy does not independently verify the accuracy or completeness of such information and explicitly disclaims responsibility for any errors or omissions.

Opinions and analysis contained within Epistrophy's research reports are current only at the time of publication and are subject to change without notice. Readers must independently verify facts and conduct their own due diligence before making investment decisions.

Epistrophy Capital Research does not consider or evaluate individual investor circumstances, including investment objectives, financial situations, or risk tolerance. Investing in securities, particularly small-cap and micro-cap stocks, involves substantial risks, including significant volatility and potential loss of principal. Readers are strongly advised to consult their financial advisor or another qualified professional before acting on any information provided. Readers should assume Epistrophy Capital Research, its principals or its contributors may have positions, long or short, any of the companies discussed and the Epistrophy Capital Research principals or contributors may have had or currently have business interests in the companies discussed.

Past performance referenced in Epistrophy reports is not indicative of future results. Security prices can fluctuate widely and investors should be aware that investments can result in significant financial losses. Unless explicitly stated otherwise, prices quoted in reports reflect market closing prices from the previous trading day.

Epistrophy Capital Research publications are intended solely for direct recipients and should not be redistributed or shared with third parties without explicit permission from Epistrophy Capital Research LLC.

Epistrophy Capital Research reports are provided strictly for informational purposes and do not constitute a comprehensive analysis of any company, security, or industry. No content within these reports should be considered accounting, tax, legal, or professional advice.

Links or references to third-party websites or external resources are provided solely for informational convenience. Epistrophy Capital Research expressly disclaims endorsement of, and responsibility for, the content, accuracy, or reliability of such external information. Accessing third-party information is done entirely at the user's own risk.

For additional details, clarification, or specific inquiries regarding Epistrophy Capital Research reports, please contact Epistrophy Capital Research LLC directly

Reply

Avatar

or to participate